Trial Number

515-15

Condition

Brain Cancer

Participant Age Range

up to 17 Months

Participant Gender

Any

Enrolling Participants

Yes

Overview

“ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma”

This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor may not need treatment until it progresses. In this case, observation may be sufficient. Measuring biomarkers in tumor cells may help plan when effective treatment is necessary and what the best treatment is. Response and biology-based risk factor-guided therapy may be effective in treating patients with non-high risk neuroblastoma and may help to avoid some of the risks and side effects related to standard treatment.

Provider

Jacqueline N Casillas, MD

Hematology-Oncology - Pediatric
Long Beach, Torrance
View Profile

Location

Miller Children’s & Women’s Hospital Long Beach

2801 Atlantic Avenue
Long Beach
(562) 933-5437
Location Details

Related Clinical Trials

Click on the category you are interested in.

Cancer Care Pediatric Care Pediatric Specialty Care Miller Children’s & Women’s Hospital Long Beach
Name
Address
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.